Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 14, 2023; 29(30): 4604-4615
Published online Aug 14, 2023. doi: 10.3748/wjg.v29.i30.4604
Published online Aug 14, 2023. doi: 10.3748/wjg.v29.i30.4604
Figure 2 Immunomodulation of the NLR family pyrin domain containing 3 inflammasome and protection against inflammatory bowel diseases.
Pathogen-associated molecular patterns from Helicobacter pylori are recognized by the NLR family pyrin domain containing 3 (NLRP3) inflammasome toll-like receptors leading to responses that appear to be associated with improved prognosis and an anti-inflammatory effect. Activated NLRP3 is able to increase the expression of caspase-1 which activates the cytokines interleukin (IL)-18 and IL-1β. The positive regulation of these cytokines leads to extragastric immunomodulation by suppressing the T helper 17 subpopulation and increasing regulatory T, transforming growth factor-β and mucins. H. pylori: Helicobacter pylori; IL: Interleukin; PAMPs: Pathogen-associated molecular patterns; TLR: Toll-like receptor; TGF: Transforming growth factor; NLRP3: NLR family pyrin domain containing 3; Treg: Regulatory T.
- Citation: Feilstrecker Balani G, dos Santos Cortez M, Picasky da Silveira Freitas JE, Freire de Melo F, Zarpelon-Schutz AC, Teixeira KN. Immune response modulation in inflammatory bowel diseases by Helicobacter pylori infection. World J Gastroenterol 2023; 29(30): 4604-4615
- URL: https://www.wjgnet.com/1007-9327/full/v29/i30/4604.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i30.4604